Annual long term debt:
$18.37B-$1.00B(-5.18%)Summary
- As of today (May 21, 2025), GSK annual long term debt is $18.37 billion, with the most recent change of -$1.00 billion (-5.18%) on December 31, 2024.
- During the last 3 years, GSK annual long term debt has fallen by -$9.40 billion (-33.85%).
- GSK annual long term debt is now -42.47% below its all-time high of $31.92 billion, reached on December 31, 2020.
Performance
GSK Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$21.31B+$2.95B(+16.04%)Summary
- As of today (May 21, 2025), GSK quarterly long term debt is $21.31 billion, with the most recent change of +$2.95 billion (+16.04%) on March 31, 2025.
- Over the past year, GSK quarterly long term debt has increased by +$2.18 billion (+11.38%).
- GSK quarterly long term debt is now -44.49% below its all-time high of $38.39 billion, reached on March 31, 2022.
Performance
GSK Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
GSK Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.2% | +11.4% |
| 3 y3 years | -33.9% | -44.5% |
| 5 y5 years | -40.6% | -30.4% |
GSK Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.9% | at low | -44.5% | +24.1% |
| 5 y | 5-year | -42.5% | at low | -44.5% | +24.1% |
| alltime | all time | -42.5% | >+9999.0% | -44.5% | >+9999.0% |
GSK Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $21.31B(+16.0%) |
| Dec 2024 | $18.37B(-5.2%) | $18.37B(+3.6%) |
| Sep 2024 | - | $17.72B(+3.2%) |
| Jun 2024 | - | $17.17B(-10.3%) |
| Mar 2024 | - | $19.13B(-1.2%) |
| Dec 2023 | $19.37B(-6.0%) | $19.37B(-0.7%) |
| Sep 2023 | - | $19.51B(-0.5%) |
| Jun 2023 | - | $19.62B(-4.8%) |
| Mar 2023 | - | $20.61B(-0.0%) |
| Dec 2022 | $20.62B(-25.7%) | $20.62B(-4.5%) |
| Sep 2022 | - | $21.58B(-5.3%) |
| Jun 2022 | - | $22.78B(-40.7%) |
| Mar 2022 | - | $38.39B(+38.3%) |
| Dec 2021 | $27.76B(-13.0%) | $27.76B(-0.3%) |
| Sep 2021 | - | $27.84B(-1.6%) |
| Jun 2021 | - | $28.29B(-10.7%) |
| Mar 2021 | - | $31.68B(-0.8%) |
| Dec 2020 | $31.92B(+3.2%) | $31.92B(+6.4%) |
| Sep 2020 | - | $30.02B(-5.2%) |
| Jun 2020 | - | $31.67B(+3.5%) |
| Mar 2020 | - | $30.60B(-1.1%) |
| Dec 2019 | $30.93B(+20.2%) | $30.93B(+1.3%) |
| Sep 2019 | - | $30.52B(+3.3%) |
| Jun 2019 | - | $29.54B(-3.0%) |
| Mar 2019 | - | $30.45B(+18.4%) |
| Dec 2018 | $25.72B(+33.4%) | $25.72B(-20.4%) |
| Sep 2018 | - | $32.32B(+0.5%) |
| Jun 2018 | - | $32.15B(+63.7%) |
| Mar 2018 | - | $19.64B(+1.9%) |
| Dec 2017 | $19.28B(+7.0%) | $19.28B(+0.4%) |
| Sep 2017 | - | $19.20B(+20.4%) |
| Jun 2017 | - | $15.95B(-12.4%) |
| Mar 2017 | - | $18.22B(+1.1%) |
| Dec 2016 | $18.01B(-20.7%) | $18.01B(-9.8%) |
| Sep 2016 | - | $19.96B(-1.8%) |
| Jun 2016 | - | $20.32B(-10.2%) |
| Mar 2016 | - | $22.63B(-0.3%) |
| Dec 2015 | $22.70B(-7.9%) | $22.70B(-0.8%) |
| Sep 2015 | - | $22.89B(-0.9%) |
| Jun 2015 | - | $23.11B(+2.5%) |
| Mar 2015 | - | $22.54B(-8.6%) |
| Dec 2014 | $24.66B(-3.3%) | $24.66B(+11.5%) |
| Sep 2014 | - | $22.12B(-10.5%) |
| Jun 2014 | - | $24.71B(-3.5%) |
| Mar 2014 | - | $25.60B(+0.5%) |
| Dec 2013 | $25.49B(+7.5%) | $25.49B(+0.7%) |
| Sep 2013 | - | $25.31B(+1.8%) |
| Jun 2013 | - | $24.86B(-5.4%) |
| Mar 2013 | - | $26.29B(+10.9%) |
| Dec 2012 | $23.71B(+26.1%) | $23.71B(+9.6%) |
| Sep 2012 | - | $21.63B(+2.7%) |
| Jun 2012 | - | $21.06B(+10.1%) |
| Mar 2012 | - | $19.13B(+1.8%) |
| Dec 2011 | $18.80B(-17.7%) | $18.80B(-15.1%) |
| Sep 2011 | - | $22.16B(-3.1%) |
| Jun 2011 | - | $22.87B(-4.0%) |
| Mar 2011 | - | $23.83B(+4.3%) |
| Dec 2010 | $22.86B | $22.86B(-2.5%) |
| Sep 2010 | - | $23.45B(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2010 | - | $22.19B(-4.0%) |
| Mar 2010 | - | $23.10B(-3.4%) |
| Dec 2009 | $23.91B(+7.2%) | $23.91B(-0.6%) |
| Sep 2009 | - | $24.05B(+11.8%) |
| Jun 2009 | - | $21.51B(-0.7%) |
| Mar 2009 | - | $21.67B(-2.9%) |
| Dec 2008 | $22.31B(+58.8%) | $22.31B(-2.2%) |
| Sep 2008 | - | $22.81B(-8.9%) |
| Jun 2008 | - | $25.04B(+55.6%) |
| Mar 2008 | - | $16.10B(+14.6%) |
| Dec 2007 | $14.05B(+50.4%) | $14.05B(+40.7%) |
| Sep 2007 | - | $9.99B(-1.0%) |
| Jun 2007 | - | $10.09B(+7.1%) |
| Mar 2007 | - | $9.42B(+0.8%) |
| Dec 2006 | $9.34B(+3.1%) | $9.34B(+2.8%) |
| Sep 2006 | - | $9.08B(+0.8%) |
| Jun 2006 | - | $9.02B(-1.9%) |
| Mar 2006 | - | $9.19B(+1.4%) |
| Dec 2005 | $9.06B(+7.8%) | $9.06B(-1.4%) |
| Sep 2005 | - | $9.20B(-1.4%) |
| Jun 2005 | - | $9.33B(+21.0%) |
| Mar 2005 | - | $7.71B(-8.2%) |
| Dec 2004 | $8.40B(+28.9%) | $8.40B(-6.7%) |
| Sep 2004 | - | $9.01B(+0.9%) |
| Jun 2004 | - | $8.93B(+34.8%) |
| Mar 2004 | - | $6.63B(+1.6%) |
| Dec 2003 | $6.52B(+30.8%) | $6.52B(+5.9%) |
| Sep 2003 | - | $6.16B(-2.6%) |
| Jun 2003 | - | $6.32B(+35.7%) |
| Mar 2003 | - | $4.66B(-6.6%) |
| Dec 2002 | $4.98B(+62.9%) | $4.98B(+18.5%) |
| Sep 2002 | - | $4.21B(+14.0%) |
| Jun 2002 | - | $3.69B(+5.1%) |
| Mar 2002 | - | $3.51B(+14.8%) |
| Dec 2001 | $3.06B(+17.2%) | $3.06B(+37.0%) |
| Sep 2001 | - | $2.23B(+1.3%) |
| Jun 2001 | - | $2.20B(-5.5%) |
| Mar 2001 | - | $2.33B(-10.6%) |
| Dec 2000 | $2.61B(+28.2%) | $2.61B(-10.1%) |
| Sep 2000 | - | $2.91B(-1.6%) |
| Jun 2000 | - | $2.95B(-2.1%) |
| Mar 2000 | - | $3.01B(+48.0%) |
| Dec 1999 | $2.04B(-31.8%) | $2.04B(-20.1%) |
| Jun 1999 | - | $2.55B(-14.5%) |
| Dec 1998 | $2.98B(-2.1%) | $2.98B(-0.3%) |
| Jun 1998 | - | $2.99B(-1.9%) |
| Dec 1997 | $3.05B(+5.6%) | $3.05B(+5.6%) |
| Dec 1996 | $2.89B(+27.0%) | $2.89B(-44.5%) |
| Dec 1995 | $2.27B(-56.3%) | - |
| Jun 1995 | - | $5.20B(+1141.0%) |
| Jun 1995 | $5.20B(+1141.0%) | - |
| Jun 1994 | $419.02M(+31.0%) | $419.02M(+31.0%) |
| Jun 1993 | $319.84M(+22.9%) | $319.84M(+22.9%) |
| Jun 1992 | $260.30M(+14.6%) | $260.30M(+14.6%) |
| Jun 1991 | $227.11M(+196.1%) | $227.11M(+196.1%) |
| Jun 1990 | $76.69M(+54.6%) | $76.69M(+54.6%) |
| Jun 1989 | $49.59M(+141.8%) | $49.59M(+141.8%) |
| Jun 1988 | $20.51M(-2.0%) | $20.51M(-2.0%) |
| Jun 1987 | $20.93M(+36.7%) | $20.93M(+36.7%) |
| Jun 1986 | $15.31M | $15.31M |
FAQ
- What is GSK annual long term debt?
- What is the all time high annual long term debt for GSK?
- What is GSK annual long term debt year-on-year change?
- What is GSK quarterly long term debt?
- What is the all time high quarterly long term debt for GSK?
- What is GSK quarterly long term debt year-on-year change?
What is GSK annual long term debt?
The current annual long term debt of GSK is $18.37B
What is the all time high annual long term debt for GSK?
GSK all-time high annual long term debt is $31.92B
What is GSK annual long term debt year-on-year change?
Over the past year, GSK annual long term debt has changed by -$1.00B (-5.18%)
What is GSK quarterly long term debt?
The current quarterly long term debt of GSK is $21.31B
What is the all time high quarterly long term debt for GSK?
GSK all-time high quarterly long term debt is $38.39B
What is GSK quarterly long term debt year-on-year change?
Over the past year, GSK quarterly long term debt has changed by +$2.18B (+11.38%)